ÂÜÀòÂÒÂ×

A board-certified oncologist, Sam has more than 25 years of experience developing specialty pharmaceutical products, including serving as founding CEO and Chairman of Jazz Pharmaceuticals, Inc. Prior to co-founding Jazz, Sam held a number of senior leadership positions at Alza Corporation (acquired by J&J), including Company Group Chairman, member of J&J’s Pharmaceutical Group Operating Committee and Senior Vice President, Medical Affairs and Group Vice President. He has also held clinical research positions in oncology at Schering-Plough Corporation, XOMA Corporation, and Genentech, Inc. He has served as Assistant Clinical Professor of Medicine in the oncology division of the Department of Medicine at the University of California, San Francisco. Sam has served as interim CMO of Threshold Pharmaceuticals and serves on the Boards of Directors for a number of companies, including Trubion Pharmaceuticals, TONIX Pharmaceuticals, Auspex Pharmaceuticals, and Cougar Biotechnology. He received his undergraduate and medical degrees from the University of Illinois.